Fig. 4.
Overall survival (A) and PFS (B) curves of patients with intermediate- and high-grade non-Hodgkin’s lymphoma. Highnm23-H1 (≥80 ng/mL) patients (n = 28) had a worse prognosis than low nm23-H1 (<80 ng/mL) patients (n = 121).
Overall survival (A) and PFS (B) curves of patients with intermediate- and high-grade non-Hodgkin’s lymphoma. Highnm23-H1 (≥80 ng/mL) patients (n = 28) had a worse prognosis than low nm23-H1 (<80 ng/mL) patients (n = 121).
